The FDA has approved a dihydroergotamine-based nasal powder for the acute treatment of migraine with or without aura in ...

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.

The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

OTC drugs that could go on retail shelves include those used for the treatment of gingivitis, paracetamol tablets 500 mg, ...

There are ways to reduce your chances of coming home from vacation with a terrible cold, digestive issues or other health ...

"It's also important to be careful when taking other medicines if you're using an all-in-one decongestant remedy," the NHS ...

DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the nasal powder formulation, ...

Indivior PLC’s recovery hinges on Sublocade’s momentum and market trends, though risks persist in litigation and earnings.

Medically reviewed by Jurairat J. Molina, MD More than 25% of the U.S. population experiences seasonal allergies, also known ...

ANSWER: This common problem is called solar purpura, and it is largely the sun causing the damage to the skin, thinning it ...

Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and ...

Sounds impressive, right? That is what the Lenovo Idea Tab Pro offers. The audio output during my first use was astounding. Despite being extremely loud, the tablet did not compromise on sound quality ...